In Relentless Pursuit of a Cancer Cure
Phase2 and Memorial Sloan Kettering Cancer Center (MSK) have been in it together for nearly a decade.
We got our start together when MSK turned to Phase2 to create their first ever enterprise-wide digital experience platform on Drupal, allowing them to efficiently publish to multiple sites.
And that was only the beginning.
I never want to downplay the impact that Phase2 has had in our success here at MSK Giving. And I always want to remind you that the work we’re doing here is impacting the trajectory of cancer treatment, diagnosis, and cure.
Simplifying Giving in a World of Change
With this platform in place, MSK and Phase2 turned our attention to the giving side of the organization. Giving is a complex digital ecosystem that aims to maximize all giving channels—from peer to peer self-organized campaigns, to special fundraising events, to corporate donations, to foundation giving, to major gifts. In other words, giving relies on the flexibility, repeatability, and speed of MSK’s platform.
Because of the constantly shifting donor landscape, speed to market for brand changes, campaigns, and new sites is paramount. The platform and our ongoing work help MSK adapt and react to maximize donations. Together, we:
- Enabled digital campaigns—freeing MSK from a reliance on direct mail donations
- Architected, built, and maintain five Drupal sites for donation and fundraising activities
- Enhanced donor and prospect experience through personalization
- Created a platform that allows for component replication and enhancement to quickly launch new campaigns and allow each brand a unique identity
Long Term Partnership = Profound Impact
The long term partnership between Phase2 and MSK has seen MSK Giving go from primarily direct mail donations to fully digital campaigns. In 2021, digital giving platforms enabled donors from 87 countries and all 50 states to contribute, and donors held 1,132 Facebook and Instagram fundraisers.
With an early investment in a robust platform, MSK has guaranteed long-lasting returns. Overall, year over year donations have increased 31%, session engagement has increased 17%, and over $190 million has been raised from Cycle for Survival alone.
Bold Discoveries, Life-changing Care
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular purpose: to find a cure for cancer. And they have been at it for 138 years.
From breakthrough clinical research to training the next generation of clinicians and scientists to providing expert, compassionate care for patients, Memorial Sloan Kettering is the unassailable leader in the pursuit of a cure.
In the digital space, MSK is the front door to a world of resources and connection and it is a mighty tool for the fundraising that fuels its efforts.
Johnson & Johnson
nVent
